The article summarizes the differentiated effects of personal account reform on the satisfaction of different in-come groups in the reform of medical insurance outpatient mutual aid.This reform has significantly improved the mutual aid pro-tection offered by medical insurance funds through comprehensive measures such as adjusting the personal account accounting method,promoting coordination of medical treatment in different places,strengthening guidance for first visits at the grassroots level,and expanding the coverage of outpatient coordination.Satisfaction levels varied significantly across income groups,with high-income groups expressing lower satisfaction due to reduced personal account accumulation.The satisfaction of the middle-in-come group increased due to the reduced burden of outpatient expenses.While low-income groups benefited from higher reim-bursement rates,the satisfaction of the above groups was moderated by limited primary care capacity.Interdisciplinary research suggested that differences in economic utility,psychological expectations,and perceptions of social justice are the root causes of differences in satisfaction among different income groups.In the future,it is advisable to fully rely on the big data of medical in-surance electronic vouchers,conduct long-term queue research,construct innovative theoretical models,and establish regional collaborative policy frameworks.This article employed AI-driven predictive modelling to assess policy responsiveness under var-ying scenarios and explored the localization of advanced foreign models,and constructed a three-tier system of"basic protection+differentiated supplements+commercial insurance",so as to promote the precise and sustainable development of the medical in-surance system.

Objective:To investigate the clinical characteristics and prognosis of fetuses with HNF1B gene variants. Methods:Fifty-two fetuses with HNF1B gene variants diagnosed by chromosomal copy number variation sequencing and/or whole exome sequencing at the First Affiliated Hospital of Zhengzhou University from January 2018 to June 2024 were retrospectively enrolled in this study, including 47 cases of 17q12 microdeletion and five cases of HNF1B point mutations. Prenatal ultrasound features, pregnancy outcomes, and postnatal manifestations were summarized and analyzed using descriptive statistics. Results:The prenatal ultrasound features of the 52 fetuses included enhanced renal parenchymal echo in 43 cases (82.7%), renal cysts in 15 cases (28.8%), enlarged kidney volume in 14 cases (26.9%), and pyelectasis in 13 cases (25.0%). Parental verification was completed for 35 cases, with 71.4% (25/35) being de novo mutations and 28.6% (10/35) inherited from either parent. Apart from eight cases with unknown pregnancy outcome (six cases were lost to follow-up, two cases refused to be followed up), the other 44 cases were successfully followed up, among which 68.2% (30/44) terminated the pregnancies and 31.8% (14/44) continued, resulting in live births. Prenatal ultrasound indicated renal abnormalities in all 14 live births, while postnatal follow-up showed seven cases with normal kidneys, one with reduced bilateral renal cysts, one with alleviated bilateral pyelectasis, four with unimproved renal structural abnormalities, and one who did not undergo a re-examination. Conclusion:The rate of renal abnormalities diagnosed by prenatal ultrasound in fetuses with HNF1B gene variants is high, and most of the pregnancies are terminated, although the renal sturctural abnormalities may improve after birth.

Objective:To evaluate the screening efficacy and clinical management strategies of cell-free fetal DNA (cffDNA) for copy number variations (CNVs) at 16p13.11-p12.3.Methods:Clinical data of 35 fetuses with high-risk indications for 16p13.11-p12.3 variations identified by non-invasive prenatal test (NIPT) at the First Affiliated Hospital of Zhengzhou University between September 2018 and December 2023 were retrospectively analyzed. Amniocentesis was performed to obtain fetal samples, followed by validation through chromosomal karyotyping and CNV-sequencing. The variant size, genetic origin, and pregnancy outcomes were systematically assessed. Statistical analysis was conducted using Pearson's Chi-square test or Fisher's exact test. Results:(1) Screening efficacy: The overall positive predictive value (PPV) of cffDNA was 45.8% (11/24), with a PPV of 4/8 for deletions and 7/16 for duplications. The false-positive rate was 54.2% (13/24), including one case complicated by a Robertsonian translocation [45,XY,rob(21;22)]. (2) Genetic characteristics: Among confirmed variants, 8/11 were inherited (six maternal duplications, one paternal deletion), while 3/11 were de novo (one deletion and two of undetermined origin). (3) Clinical outcomes: Among live births, 3/9 confirmed cases exhibited abnormal manifestations, including conductive hearing loss (one case with maternal duplication), language developmental delay (one case with 16p13.11 tetrasomy combined with trisomy), and hypotonia (one case with de novo deletion). Follow-up of false-negative or undiagnosed fetuses (22 cases) and 6/9 of confirmed cases showed no abnormalities. Conclusion:CNVs at 16p13.11-p12.3 demonstrate significant incomplete penetrance. Invasive diagnosis combined with familial analysis is recommended for cffDNA-positive cases. Genetic counseling should emphasize variant size and parental origin, and long-term neurodevelopmental follow-up mechanisms should be established for confirmed fetuses.

Objective To explore the diagnostic value of CT imaging of creeping fat(CF)combined with serum optimization indicators for active Crohn's disease(CD).Methods The data from 68 cases underwent small intestine CT examinations(43 cases in the active CD group and 25 cases in the control group)were collected.CF imaging(non-contrast CT value,enhanced ΔCT value,submucosal fat deposition,and extent of intestinal wrapping)and serum optimization indicators[including neutrophil-to-lymphocyte ratio(NLR),C-reactive protein-to-albumin ratio(CAR),platelet-to-lymphocyte ratio(PLR),platelet-to-albumin ratio(PAR),neutrophil percentage-to-albumin ratio(NPAR),systemic immune-inflammation index(SII),lymphocyte-to-monocyte ratio(LMR),and albumin-to-globulin ratio(AGR)]were evaluated.The correlation between these idictors and CD activity were evaluated.Logistic regression and receiver operating characteristic(ROC)curve analysis were used to assess the diagnostic value of individual and combined indicators for active CD.Results Significant differences were observed in CF imaging and serum optimization indicators between the mild to moderate active CD groups and the control group(P<0.05).The area under the curve(AUC)for non-contrast CT value,arterial phase ΔCT value,venous phase ΔCT value,CF score,NLR,CAR,PLR,PAR,NPAR,SII and combined indicators in predicting moderate active CD were 0.914,0.856,0.923,0.703,0.902,0.880,0.858,0.717,0.802,0.875 and 0.972,respectively.Among these,venous phase ΔCT value and SII exhibited the highest sensitivity(100%),while non-contrast CT value and NPAR demonstrated the highest specificity(87.5%).Venous phase ΔCT value and CAR were identified as significant predictors of moderate active CD(P<0.05).Additionally,serum optimization indicators were significantly correlated with CF imaging(P<0.01).Conclusion CF imaging and serum optimization indicators serve as potential non-invasive markers for diagnosing active CD,with higher diagnostic value achieved through combined assessments.Venous phase ΔCT value and CAR are promising predictors for moderate active CD.

The article summarizes the differentiated effects of personal account reform on the satisfaction of different in-come groups in the reform of medical insurance outpatient mutual aid.This reform has significantly improved the mutual aid pro-tection offered by medical insurance funds through comprehensive measures such as adjusting the personal account accounting method,promoting coordination of medical treatment in different places,strengthening guidance for first visits at the grassroots level,and expanding the coverage of outpatient coordination.Satisfaction levels varied significantly across income groups,with high-income groups expressing lower satisfaction due to reduced personal account accumulation.The satisfaction of the middle-in-come group increased due to the reduced burden of outpatient expenses.While low-income groups benefited from higher reim-bursement rates,the satisfaction of the above groups was moderated by limited primary care capacity.Interdisciplinary research suggested that differences in economic utility,psychological expectations,and perceptions of social justice are the root causes of differences in satisfaction among different income groups.In the future,it is advisable to fully rely on the big data of medical in-surance electronic vouchers,conduct long-term queue research,construct innovative theoretical models,and establish regional collaborative policy frameworks.This article employed AI-driven predictive modelling to assess policy responsiveness under var-ying scenarios and explored the localization of advanced foreign models,and constructed a three-tier system of"basic protection+differentiated supplements+commercial insurance",so as to promote the precise and sustainable development of the medical in-surance system.

Objective To explore the diagnostic value of CT imaging of creeping fat(CF)combined with serum optimization indicators for active Crohn's disease(CD).Methods The data from 68 cases underwent small intestine CT examinations(43 cases in the active CD group and 25 cases in the control group)were collected.CF imaging(non-contrast CT value,enhanced ΔCT value,submucosal fat deposition,and extent of intestinal wrapping)and serum optimization indicators[including neutrophil-to-lymphocyte ratio(NLR),C-reactive protein-to-albumin ratio(CAR),platelet-to-lymphocyte ratio(PLR),platelet-to-albumin ratio(PAR),neutrophil percentage-to-albumin ratio(NPAR),systemic immune-inflammation index(SII),lymphocyte-to-monocyte ratio(LMR),and albumin-to-globulin ratio(AGR)]were evaluated.The correlation between these idictors and CD activity were evaluated.Logistic regression and receiver operating characteristic(ROC)curve analysis were used to assess the diagnostic value of individual and combined indicators for active CD.Results Significant differences were observed in CF imaging and serum optimization indicators between the mild to moderate active CD groups and the control group(P<0.05).The area under the curve(AUC)for non-contrast CT value,arterial phase ΔCT value,venous phase ΔCT value,CF score,NLR,CAR,PLR,PAR,NPAR,SII and combined indicators in predicting moderate active CD were 0.914,0.856,0.923,0.703,0.902,0.880,0.858,0.717,0.802,0.875 and 0.972,respectively.Among these,venous phase ΔCT value and SII exhibited the highest sensitivity(100%),while non-contrast CT value and NPAR demonstrated the highest specificity(87.5%).Venous phase ΔCT value and CAR were identified as significant predictors of moderate active CD(P<0.05).Additionally,serum optimization indicators were significantly correlated with CF imaging(P<0.01).Conclusion CF imaging and serum optimization indicators serve as potential non-invasive markers for diagnosing active CD,with higher diagnostic value achieved through combined assessments.Venous phase ΔCT value and CAR are promising predictors for moderate active CD.

Objective:To investigate the clinical characteristics and prognosis of fetuses with HNF1B gene variants. Methods:Fifty-two fetuses with HNF1B gene variants diagnosed by chromosomal copy number variation sequencing and/or whole exome sequencing at the First Affiliated Hospital of Zhengzhou University from January 2018 to June 2024 were retrospectively enrolled in this study, including 47 cases of 17q12 microdeletion and five cases of HNF1B point mutations. Prenatal ultrasound features, pregnancy outcomes, and postnatal manifestations were summarized and analyzed using descriptive statistics. Results:The prenatal ultrasound features of the 52 fetuses included enhanced renal parenchymal echo in 43 cases (82.7%), renal cysts in 15 cases (28.8%), enlarged kidney volume in 14 cases (26.9%), and pyelectasis in 13 cases (25.0%). Parental verification was completed for 35 cases, with 71.4% (25/35) being de novo mutations and 28.6% (10/35) inherited from either parent. Apart from eight cases with unknown pregnancy outcome (six cases were lost to follow-up, two cases refused to be followed up), the other 44 cases were successfully followed up, among which 68.2% (30/44) terminated the pregnancies and 31.8% (14/44) continued, resulting in live births. Prenatal ultrasound indicated renal abnormalities in all 14 live births, while postnatal follow-up showed seven cases with normal kidneys, one with reduced bilateral renal cysts, one with alleviated bilateral pyelectasis, four with unimproved renal structural abnormalities, and one who did not undergo a re-examination. Conclusion:The rate of renal abnormalities diagnosed by prenatal ultrasound in fetuses with HNF1B gene variants is high, and most of the pregnancies are terminated, although the renal sturctural abnormalities may improve after birth.

Objective:To evaluate the screening efficacy and clinical management strategies of cell-free fetal DNA (cffDNA) for copy number variations (CNVs) at 16p13.11-p12.3.Methods:Clinical data of 35 fetuses with high-risk indications for 16p13.11-p12.3 variations identified by non-invasive prenatal test (NIPT) at the First Affiliated Hospital of Zhengzhou University between September 2018 and December 2023 were retrospectively analyzed. Amniocentesis was performed to obtain fetal samples, followed by validation through chromosomal karyotyping and CNV-sequencing. The variant size, genetic origin, and pregnancy outcomes were systematically assessed. Statistical analysis was conducted using Pearson's Chi-square test or Fisher's exact test. Results:(1) Screening efficacy: The overall positive predictive value (PPV) of cffDNA was 45.8% (11/24), with a PPV of 4/8 for deletions and 7/16 for duplications. The false-positive rate was 54.2% (13/24), including one case complicated by a Robertsonian translocation [45,XY,rob(21;22)]. (2) Genetic characteristics: Among confirmed variants, 8/11 were inherited (six maternal duplications, one paternal deletion), while 3/11 were de novo (one deletion and two of undetermined origin). (3) Clinical outcomes: Among live births, 3/9 confirmed cases exhibited abnormal manifestations, including conductive hearing loss (one case with maternal duplication), language developmental delay (one case with 16p13.11 tetrasomy combined with trisomy), and hypotonia (one case with de novo deletion). Follow-up of false-negative or undiagnosed fetuses (22 cases) and 6/9 of confirmed cases showed no abnormalities. Conclusion:CNVs at 16p13.11-p12.3 demonstrate significant incomplete penetrance. Invasive diagnosis combined with familial analysis is recommended for cffDNA-positive cases. Genetic counseling should emphasize variant size and parental origin, and long-term neurodevelopmental follow-up mechanisms should be established for confirmed fetuses.

ObjectiveThis study observes the intervention effect of Longmu Piyan prescription on oxidative stress in BALB/c mice with atopic dermatitis （AD） induced by 2，4-dinitrochlorobenzene （DNCB） and explores its mechanism. MethodThe AD model was established using the method of DNCB sensitization on the back skin of BALB/c mice. Forty male BALB/c mice were randomly divided into a blank group， a model group， a vitamin C control group （0.5×10^-3 mg·kg^-1）， and a Longmu Piyan prescription group （26 g·kg^-1）. Except for the blank group， other groups were sensitized with different concentrations of DNCB on the back to induce AD， and the blank group was treated with matrix coating. The gastric administration was started on the seventh day after sensitization with 2% DNCB and on the 24th day after sensitization with 0.2% DNCB continuously for 21 days. The changes in skin lesions of each group were directly observed after the experiment. Enzyme-linked immunosorbent assay （ELISA） was used to detect the levels of interleukin （IL）-4， tumor necrosis factor （TNF）-α， immunoglobulin E （IgE）， and reactive oxygen species （ROS） in the serum of each group. The total antioxidant capacity determination kit-trace method (ABTS method) was used to measure the level of total antioxidant capacity （TAOC） in serum. The Hematoxylin eosin （HE） staining method was used to observe the pathological and morphological changes of the skin lesion site. The immunohistochemical method was used to detect the expression of thymic stromal lymphopoietin （TSLP） in the skin lesion site. Western blot was used to detect the expression of filaggrin （FLG） in the dorsal skin lesions. ResultThe results showed that compared with the blank group， the skin lesion score of the model group mice was significantly increased （P<0.01）， and HE staining showed characteristic pathological changes of AD in the skin lesion site. At the same time， the expression of TSLP in the skin lesion was significantly increased， and that of FLG was reduced （P<0.05）. The levels of TNF-α， IL-4， IgE， and ROS in serum increased， while the activity of TAOC decreased （P<0.01）. Compared with the model group， the Longmu Piyan prescription group showed a significant decrease in skin lesion scores and a significant improvement in skin lesion pathology. At the same time， the expression of TSLP decreased， and the expression of FLG increased in the skin lesions （P<0.05）. In addition， compared with the model group， the serum levels of TNF-α， IL-4， IgE， and ROS also decreased to varying degrees （P<0.05，P<0.01）， and TAOC activity increased in the Longmu Piyan prescription group （P<0.01）. ConclusionThere is a significant correlation among the degree of oxidative stress， the severity of skin lesions in AD， and the levels of inflammatory cytokines. Longmu Piyandu prescription can improve AD-like skin lesions in BALB/c mice by promoting ROS clearance， enhancing TAOC， and inhibiting oxidative stress， thus protecting the skin barrier and reducing inflammation.

OBJECTIVE: To carry out prenatal diagnosis for a fetus with normal ultrasonographic finding at 20 weeks' gestation but a copy number variant(CNV) of 13q indicated by non-invasive prenatal test (NIPT). METHODS: Karyotyping analysis and chromosomal CNV assay were carried out on the amniotic fluid sample. Parental peripheral blood sample was collected for chromosomal analysis. Detailed fetal ultrasound scan was carried out to rule out structural abnormalities of the fetus. RESULTS: The fetus was detected with a heterozygous 10.14 Mb deletion at 13q21.1q21.32, which has originated from the phenotypically normal mother. No apparent karyotypic abnormality was detected in the fetus and its parents. No ultrasonic abnormality was found in the fetus. CONCLUSION Both the fetus and its mother have carried a heterozygous 10.14 Mb deletion at 13q21.1q21.32 and presented normal phenotypes.Combined with literature review, the segmental deletion was judged to be a benign variant.
Female ; Genetic Counseling ; Humans ; Karyotyping ; Pedigree ; Pregnancy ; Prenatal Diagnosis ; Ultrasonography, Prenatal